Birkenbihl, Colin
Ahmad, Ashar
Massat, Nathalie J.
Raschka, Tamara
Avbersek, Andreja
Downey, Patrick
Armstrong, Martin
Fröhlich, Holger
Funding for this research was provided by:
Horizon 2020 Framework Programme (826421, 826421)
ERAPerMed (01KU2110, 01KU2110)
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI
Article History
Received: 2 August 2022
Accepted: 14 February 2023
First Online: 18 February 2023
Competing interests
: PD and MA are employees of UCB BioPharma. HF, AAh, and AAv were full time employees of UCB BioPharma at the start of this study. NJM is a Veramed statistical consultant for UCB Biopharma.